Vanguard Group’s Quince Therapeutics QNCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$6.98M Buy
10,420
+1,603
+18% +$807K ﹤0.01% 3128
2025
Q3
$2.87M Buy
8,817
+1,547
+21% +$515K ﹤0.01% 3460
2025
Q2
$2.4M Buy
7,270
+841
+13% +$192K ﹤0.01% 3479
2025
Q1
$1.71M Buy
6,429
+67
+1% +$20.5K ﹤0.01% 3543
2024
Q4
$2.38M Buy
6,362
+364
+6% +$109K ﹤0.01% 3511
2024
Q3
$931K Sell
5,998
-75
-1% -$10.7K ﹤0.01% 3795
2024
Q2
$911K Buy
6,073
+415
+7% +$75K ﹤0.01% 3816
2024
Q1
$1.2M Buy
5,658
+799
+16% +$199K ﹤0.01% 3750
2023
Q4
$1.02M Buy
4,859
+109
+2% +$21.8K ﹤0.01% 3822
2023
Q3
$1.06M Buy
4,750
+284
+6% +$74.2K ﹤0.01% 3808
2023
Q2
$1.34M Hold
4,466
﹤0.01% 3804
2023
Q1
$1.39M Buy
4,466
+199
+5% +$38.9K ﹤0.01% 3806
2022
Q4
$544K Sell
4,267
-93
-2% -$15.6K ﹤0.01% 4074
2022
Q3
$1.16M Buy
4,360
+420
+11% +$160K ﹤0.01% 3955
2022
Q2
$1.75M Sell
3,940
-1,697
-30% -$1.2M ﹤0.01% 3861
2022
Q1
$6.98M Buy
5,637
+252
+5% +$343K ﹤0.01% 3349
2021
Q4
$13.6M Buy
5,385
+320
+6% +$1.95M ﹤0.01% 3059
2021
Q3
$92.8M Buy
5,065
+483
+11% +$7.68M ﹤0.01% 2013
2021
Q2
$48.6M Buy
4,582
+298
+7% +$2.5M ﹤0.01% 2390
2021
Q1
$30.9M Buy
4,284
+695
+19% +$5M ﹤0.01% 2576
2020
Q4
$19.9M Buy
3,589
+97
+3% +$859K ﹤0.01% 2631
2020
Q3
$34.9M Buy
3,492
+493
+16% +$4.48M ﹤0.01% 2198
2020
Q2
$27.8M Buy
2,999
+753
+34% +$6.9M ﹤0.01% 2272
2020
Q1
$20.5M Buy
2,246
+188
+9% +$1.86M ﹤0.01% 2273
2019
Q4
$23.1M Buy
2,058
+891
+76% +$5.38M ﹤0.01% 2462
2019
Q3
$5.82M Buy
1,167
+293
+34% +$1.8M ﹤0.01% 3083
2019
Q2
$7.43M Buy
+874
New +$5.22M ﹤0.01% 3023

Other funds holding QNCX